Kobayashi Pharmaceutical has a total of 5870 patents globally, out of which 3891 have been granted. Of these 5870 patents, more than 58% patents are active. Japan is where Kobayashi Pharmaceutical has filed the maximum number of patents, followed by China and Taiwan. Parallelly, Japan seems to be the main focused R&D centre and also is the origin country of Kobayashi Pharmaceutical.
Kobayashi Pharmaceutical was founded in the year 1919. The Company manufactures and wholesales pharmaceuticals and medical equipment. The Company also develops and manufactures fragrances, deodorant, sanitary products and ointment for stiff shoulders, as well as exports to Southeast Asia and the US. As of March 2023, the market cap of Kobayashi Pharmaceutical is $4.81 Billion.
Do read about some of the most popular patents of Kobayashi Pharmaceutical which have been covered by us in this article and also you can find Kobayashi Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kobayashi Pharmaceutical patent portfolio.
How many patents does the CEO of Kobayashi Pharmaceutical have?
The CEO Akihiro Kobayashi has 15 patents.
How many patents does Kobayashi Pharmaceutical have?
Kobayashi Pharmaceutical has a total of 5870 patents globally. These patents belong to 4371 unique patent families. Out of 5870 patents, 3411 patents are active.
How Many Patents did Kobayashi Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kobayashi Pharmaceutical Applications Filed | Kobayashi Pharmaceutical Patents Granted |
| 2023 | – | 32 |
| 2022 | 93 | 329 |
| 2021 | 280 | 359 |
| 2020 | 426 | 261 |
| 2019 | 518 | 222 |
| 2018 | 500 | 177 |
| 2017 | 322 | 144 |
| 2016 | 352 | 216 |
| 2015 | 329 | 215 |
| 2014 | 216 | 219 |
| 2013 | 206 | 219 |
| 2012 | 207 | 203 |
How many Kobayashi Pharmaceutical patents are Alive/Dead?
How Many Patents did Kobayashi Pharmaceutical File in Different Countries?
Countries in which Kobayashi Pharmaceutical Filed Patents
| Country | Patents |
| Japan | 4138 |
| China | 296 |
| Taiwan | 221 |
| United States Of America | 123 |
| Hong Kong (S.A.R.) | 98 |
| Europe | 59 |
| Korea (South) | 44 |
| United Kingdom | 40 |
| Australia | 39 |
| Singapore | 34 |
| Indonesia | 24 |
| Malaysia | 22 |
| Viet Nam | 20 |
| Thailand | 17 |
| Germany | 17 |
| Philippines | 15 |
| Canada | 13 |
| Macao | 10 |
| New Zealand | 3 |
| United Arab Emirates | 2 |
| Saudi Arabia | 1 |
Where are Research Centres of Kobayashi Pharmaceutical Patents Located?
10 Best Kobayashi Pharmaceutical Patents
US20040157954A1 is the most popular patent in the Kobayashi Pharmaceutical portfolio. It has received 49 citations so far from companies like Depuy Spine, Mitsui Chemicals and Heraeus Medical.
Below is the list of 10 most cited patents of Kobayashi Pharmaceutical:
| Publication Number | Citation Count |
| US20040157954A1 | 49 |
| WO2007100104A1 | 47 |
| JP2005104924A | 42 |
| JP2004230127A | 41 |
| JP2003113059A | 37 |
| USD630759S1 | 36 |
| USD627078S1 | 27 |
| USD655821S1 | 27 |
| USD627896S1 | 27 |
| USD627076S1 | 26 |
How many inventions of other companies were rejected due to Kobayashi Pharmaceutical patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Kobayashi Pharmaceutical’s invention. They couldn’t because Kobayashi Pharmaceutical had protected those before them.
Examiners at the USPTO referred 14 Kobayashi Pharmaceutical patents in 29 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Kobayashi Pharmaceutical patent portfolio are Kao Corporation, The Hong Kong Research Institute Of Textiles and Individual.
List of the Companies whose Patents were rejected citing Kobayashi Pharmaceutical –
| Company | Number of Patent Applications that faced Rejection Citing Kobayashi Pharmaceutical Patents | Number of Rejections (102 & 103) |
| Kao Corporation | 2 | 3 |
| The Hong Kong Research Institute Of Textiles | 2 | 3 |
| Individual | 2 | 2 |
| Cool Flash | 1 | 1 |
| Caster | 1 | 2 |
| Rechargeable Battery Corporation | 1 | 2 |
| Ebb Therapeutics | 1 | 2 |
| West Rock Shared Services | 1 | 2 |
| Heraeus Medical | 1 | 1 |
| Paratus Diagnostics | 1 | 1 |
Count of 102 and 103 Type Rejections based on Kobayashi Pharmaceutical Patents
Top Kobayashi Pharmaceutical Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US6524612B2 | 4 |
| US9056968B2 | 2 |
| US9920954B2 | 2 |
| US20090125086A1 | 2 |
| US9334080B2 | 1 |
| US6919081B1 | 1 |
| US6585974B1 | 1 |
| US10695215B2 | 1 |
| US20040157954A1 | 1 |
| US9945584B2 | 1 |
| US20060286616A1 | 1 |
| US10980665B2 | 1 |
| US10195074B2 | 1 |
| US20090142321A1 | 1 |
What Percentage of Kobayashi Pharmaceutical US Patent Applications were Granted?
Kobayashi Pharmaceutical (Excluding its subsidiaries) has filed 86 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 44 have been granted leading to a grant rate of 74.58%.
Below are the key stats of Kobayashi Pharmaceutical patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Kobayashi Pharmaceutical?
| Law Firm | Total Applications | Success Rate |
| Kratz Quintos & Hanson | 26 | 83.33% |
| Locke Lord | 15 | 58.33% |
| Birch Stewart Kolasch & Birch | 12 | 100.00% |
| Knobbe Martens Olson & Bear | 9 | 80.00% |
| Wolf Greenfield & Sacks | 4 | 100.00% |
| Koda & Androlia | 3 | 33.33% |
| Greenblum & Bernstein | 2 | 0.00% |
| Hamre Schumann Mueller & Larson | 2 | 100.00% |
| Mh2 Technology Law Group | 2 | 0% |
| Morgan Lewis & Bockius | 2 | 0% |